In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- Drug Master File in Korea (2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-. The MFDS reviews the 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- KDMF as part of the drug registration process and uses the information provided in the 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- KDMF to evaluate the safety and efficacy of the drug.
After submitting a 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 2,4-Dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)- suppliers with KDMF on PharmaCompass.